Aug 8 (Reuters) - Clayton, Dubilier & Rice (CD&R) is close to raising $23 billion for its new flagship buyout fund, overshooting its initial target by $3 billion to defy an industry-wide slump in ...

Sanofi announces today the closing of the sale to CD&R of a 50.0% controlling stake of its consumer healthcare business Opella. Sanofi retains a significant shareholding of Opella with a 48.2% stake.

Clayton, Dubilier & Rice (CD&R), a private investment firm, and TPG Capital will acquire animal-health technology and services company Covetrus Inc (NASDAQ: CVET) for $21.00 per share ...

PARIS, Oct 21 (Reuters) - French drugmaker Sanofi (SASY.PA), opens new tab said on Monday it had entered exclusive talks to sell a 50% controlling stake in its consumer health business Opella to U ...

NEW YORK, Nov. 2, 2017 /PRNewswire/ — Clayton, Dubilier & Rice announced today an agreement under which CD&R-managed funds will acquire a majority stake in SunSource Holdings, Inc., a ...

MURRAY, Utah, Nov. 19, 2024 (GLOBE NEWSWIRE) -- R1 RCM Inc. (“R1”), a leader in automating revenue management for healthcare providers, today announced that investment funds affiliated with ...

Sir Terry Leahy, former CEO of Tesco and senior adviser to CD&R. Photo: Matthew Lloyd/Getty Images for ReSource 2012 · Matthew Lloyd via Getty Images Clayton, Dubilier & Rice (CD&R) is the shadowy US ...

The investment is strategic for CD&R and not a prelude to a takeover of Pegasystems, said one of the people, asking not to be identified because the matter is private. Terms aren’t finalized and ...

April 2 (Reuters) - U.S. private equity firm Clayton Dubilier & Rice (CD&R) said on Tuesday it had agreed to acquire a majority ownership position in information technology provider Presidio from ...

"We believe that as a private company with the expertise and support of experienced investors such as CD&R and KKR, Cloudera will have the resources and flexibility to drive product-led growth and ...